Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0085631 (agitation)
 12,064 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Two enzyme-linked immunosorbent assays were developed for detection of staphylococcal exfoliative toxins A and B (ETA and ETB) with a double-antibody sandwich protocol. Antibodies against both toxins were purified by affinity chromatography from sheep antisera raised against purified ETA and ETB. These affinity-purified antibodies were free of detectable amounts of antibodies to other staphylococcal antigens and neutralized the actions of ETA and ETB. Alkaline phosphatase was conjugated to these antibodies. The enzyme-linked immunosorbent assay, which could detect at least 3 ng of ETA and ETB per ml, was used to quantitate the toxins in the culture supernatant fluids of staphylococcal strains. Thus, the kinetics of ETA and ETB synthesis and of ETA and ETB release into the supernatant fluids were determined; other determinations included the roles of carbon dioxide concentration, pH, glucose concentration, temperature, and agitation on the production of ETA and ETB.
 ...
PMID:Enzyme-linked immunosorbent assays for Staphylococcus aureus exfoliative toxins A and B and some applications. 639 14

Endothelin (ET)-A and ET-B receptors have been reported to exist in the spinal cord but the roles of ET-A and ET-B receptors in the spinal cord are poorly understood. To gain a better understanding of the roles of ET-A and ET-B receptors in nociceptive information transmission in the spinal cord, this study evaluated the effects of ET-1, ET-3, Sarafotoxin S6c (an ET-B receptor-selective agonist) and (R)2-[(R)-2-[(S)-2-[[1- (hexahydro-1H-azepinyl)]carbonyl]amino-4-methyl-pentanoyl]amino-3- [3-(1-methyl-1H-indolyl)]propionyl]amino-3-(2-pyridyl)propionic acid (FR139317, an ET-A receptor-selective antagonist) on the agitation behavior evoked by formaldehyde solution injection and on the thermal nociceptive test. The s.c. injection of formaldehyde solution into the hind paw evoked a biphasic flinching (phase 1, 0-9 min; phase 2, 10-60 min) of the injected paw. For the purpose of data analysis, phase 2 was further divided into two phases (phase 2a, 10-34 min; phase 2b, 35-60 min). Intrathecal injection of ET-1 depressed the phase 1 and 2 flinching behavior in a dose-dependent manner and this ET-1 effect was antagonized by FR139317. Intrathecal injection of either ET-3 or Sarafotoxin S6c enhanced the phase 2a flinching behavior in a dose-dependent manner. Intrathecal injection of the highest doses of ET-1, ET-3 and Sarafotoxin S6c had no effect on the thermal nociceptive test. These data indicate that ET-A and ET-B receptors have a powerful effect on spinal nociceptive processing evoked by formaldehyde solution injection but not that evoked by thermal stimulation.
 ...
PMID:Analysis of the role of endothelin-A and endothelin-B receptors on nociceptive information transmission in the spinal cord with FR139317, an endothelin-A receptor antagonist, and sarafotoxin S6c, an endothelin-B receptor agonist. 796 9